Bogart Wealth, LLC Charles River Laboratories International, Inc. Transaction History

Bogart Wealth, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	SELL	$197.11 - $250.07 $8,081 - $10,252	-41 Closed	0 $0
Q3 2022 Nov 03, 2022	BUY	$182.44 - $250.54 $5,473 - $7,516	30 Added 272.73%	41 $8,000
Q2 2022 Jul 22, 2022	BUY	$204.13 - $302.4 $2,245 - $3,326	11 New	11 $2,000
Q1 2022 Apr 22, 2022	BUY	$255.51 - $362.11 $0 - $0	0 New	0 $0
Q4 2021 Jan 19, 2022	BUY	$351.38 - $448.68 $0 - $0	0 New	0 $0
Q1 2021 Apr 16, 2021	SELL	$249.67 - $299.48 $0 - $0	0 Closed	0 $0
Q4 2020 Jan 14, 2021	BUY	$222.0 - $252.62 $0 - $0	0 New	0 $0

695

52.2M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.45B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Bogart Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Bogart Wealth, LLC with notifications on news.